Rapidly evolving demographic trends, regulatory policies, increased drug pipelines and advent of Covid 19 are currently some of the biggest forces affecting and influencing the present and the future possibilities of the healthcare industry. Leading companies in the sectors of Medtech, Biopharma and Healthcare IT have been deeply impacted by the vulnerabilities and the uncertainty of the pandemic and are trying their best to find better solutions, combating long-term health threats. Further several macro-trends are redefining the ‘delivery of care’ and companies are constantly seeking patient centric strategies to build trust and transparency among its stakeholders. It is therefore needless to say, that considering the current anomalous situation, a coherent prediction could only be made by the experienced advisors in the industry.